CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This phase I trial studies the sides effects and best dose of hydroxychloroquine when given together with trametinib in treating patients with pancreatic...
Phase 1
Salt Lake City, Utah, United States and 1 other location
ONIVYDE + LV + 5-FU chemotherapy regimen in patients with advanced pancreatic cancer and to determine the recommended dose for the ...
Phase 1, Phase 2
Ogden, Utah, United States of America and 27 other locations
Pancreatic cancer is difficult to diagnose early. By the time people have been diagnosed, the cancer has usually spread to ...
Phase 3
Salt Lake City, Utah, United States and 12 other locations
Zolbetuximab is being studied as a treatment for people with pancreatic cancer. Most people with pancreatic cancer...
Phase 2
Salt Lake City, Utah, United States and 135 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 11 other locations
This phase II study evaluates how well pemigatinib works for the treatment of adult patients with pancreatic cancer that has spread...
Phase 2
Salt Lake City, Utah, United States and 108 other locations
This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, ...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 7 other locations
The purpose of this study is to evaluate the safety and efficacy of a novel RAS(ON) inhibitor compared to standard of care (SOC) observation only.
Phase 3
Salt Lake City, Utah, United States and 16 other locations
TNG462-C102 is a Phase 1/2, open-label, multicenter study designed to determine the safety, tolerability, PK, PD, and preliminary antineoplastic acti...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 17 other locations
This study will assess the safety and efficacy of VS-7375 alone and in combination in patients with advanced solid tumors harboring a KRAS G...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 13 other locations
Clinical trials
Research sites
Resources
Legal